Recombinant TNFSF11 (Denosumab Biosimilar) 抗体
-
- 抗原 See all TNFSF11 (Denosumab Biosimilar) products
- TNFSF11 (Denosumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This TNFSF11 (Denosumab Biosimilar) antibody is un-conjugated
- 应用范围
- Flow Cytometry (FACS), In vivo Studies (in vivo)
- 原理
- Denosumab Biosimilar, Human RANKL Monoclonal Antibody
- 特异性
- The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.
- 产品特性
- Recombinant Humanized IgG2 Monoclonal Antibody.
- 纯化方法
- Protein A affinity column
- 纯度
- > 95% by SDS-PAGE under reducing conditions and HPLC.
- 过滤
- 0.2 μm filtered
- 内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method.
- 免疫原
- The monoclonal antibody denosumab biosimilar was produced in the denosumab biosimilar CHO stable cell line.
- 亚型
- IgG2 kappa
-
-
- 应用备注
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- PBS, pH 7.4, no stabilizers or preservatives.
- 储存液
- Without preservative
- 注意事项
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
- 有效期
- 12 months
-
- 抗原
- TNFSF11 (Denosumab Biosimilar)
- Abstract
- TNFSF11 (Denosumab Biosimilar) 产品
- 别名
- CD254 antibody, ODF antibody, OPGL antibody, OPTB2 antibody, RANKL antibody, TRANCE antibody, hRANKL2 antibody, sOdf antibody, TNF superfamily member 11 antibody, TNFSF11 antibody
- 物质类
- Biosimilar
- 背景
- Denosumab, a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.
-